Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Inflammatory Breast Neoplasms × Letrozole × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Polycystic Ovary Syndrome 2 Uterine Neoplasms 1 Neoplasm Metastasis 1 Inflammatory Breast Neoplasms 1 Infertility 1 Hydatidiform Mole 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 Gestational Trophoblastic Disease 1 Endometrial Neoplasms 1 Carcinoma, Ductal, Breast 1

Interventions

Paclitaxel 2 Taxes 1 Neoadjuvant Therapy 1 Letrozole 1 Lapatinib 1 Gonadotropin-Releasing Hormone 1 Doxorubicin 1 Cisplatin 1 Carboplatin 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02221999 2023-08-29

SHPD002

RenJi Hospital

Phase 2/3 Active not recruiting

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡